These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 2839208)
1. [Specific immunostimulation in the therapy of recurrent herpes simplex type I or II]. Veneroni G; Calixte C; Bozzo Costa E; Germogli R Boll Ist Sieroter Milan; 1987; 66(6):427-34. PubMed ID: 2839208 [TBL] [Abstract][Full Text] [Related]
2. Seventeen years of application of herpes vaccines in Bulgaria. Dundarov S; Andonov P Acta Virol; 1994 Aug; 38(4):205-8. PubMed ID: 7879710 [TBL] [Abstract][Full Text] [Related]
3. [Short-term therapeutic effect of an inactivated herpes simplex virus type 1 vaccine on herpes simplex keratitis]. Zhang YQ Zhonghua Yan Ke Za Zhi; 1983 Nov; 19(6):339-42. PubMed ID: 6327206 [No Abstract] [Full Text] [Related]
6. [Treatment of recurrent herpes labialis using a herpes simplex Type-I subunit vaccine. A prospective randomized double-blind multicenter study]. Altmeyer P; Wehrenberg O; Holzmann H; Paul E; Kimmig WK; Wassilew SW; Petres J; Korger G Hautarzt; 1991 Dec; 42(12):759-63. PubMed ID: 1662671 [TBL] [Abstract][Full Text] [Related]
7. Therapy of herpes simplex with heat inactivated Herpes virus hominis type 1 and type 2. Kitagawa K Z Hautkr; 1973 Jul; 48(13):533-5. PubMed ID: 4361462 [No Abstract] [Full Text] [Related]
8. [Complex treatment and prevention of recurrence in patients with ocular herpes]. Gorgiladze TU; Gaĭdamaka TB Oftalmol Zh; 1987; (3):157-61. PubMed ID: 3037460 [No Abstract] [Full Text] [Related]
9. [Specific and unspecific immune stimulation in recurrent herpes simplex]. Raab W Z Hautkr; 1977 May; 52(10):565-72. PubMed ID: 195407 [TBL] [Abstract][Full Text] [Related]
10. [Antiherpetic cultural inactivated divaccine (experience in its preparation and study of its therapeutic effectiveness)]. Bikbulatov RM; Demidova SA; Alekseeva AA; Cheglakov IuA; Kozlova VI Sov Med; 1983; (3):50-4. PubMed ID: 6304919 [No Abstract] [Full Text] [Related]
11. [Herpes simplex]. Fanta D Wien Klin Wochenschr; 1981 Dec; 93(24):739-44. PubMed ID: 6281991 [TBL] [Abstract][Full Text] [Related]
13. Human fibroblast interferon in treatment of viral diseases of the skin and mucous membranes. Isacsohn M; Berson B; Sternberg I; Morag A Isr J Med Sci; 1983 Nov; 19(11):959-62. PubMed ID: 6319325 [TBL] [Abstract][Full Text] [Related]
14. [Nonspecific immune stimulation with BCG in Herpes simplex recidivans. Follow-up 5 to 10 years after BCG vaccination]. Hippmann G; Wekkeli M; Rosenkranz AR; Jarisch R; Götz M Wien Klin Wochenschr; 1992; 104(7):200-4. PubMed ID: 1523844 [TBL] [Abstract][Full Text] [Related]
16. [Recurrent herpes in patients with different diseases of the internal organs]. Khamaganova IV Ter Arkh; 1991; 63(10):154-6. PubMed ID: 1666694 [No Abstract] [Full Text] [Related]
17. Immunotherapy with inactivated polyvalent herpes vaccines. Dundarov S; Andonov P; Bakalov B; Nechev K; Tomov C Dev Biol Stand; 1982; 52():351-8. PubMed ID: 6299844 [No Abstract] [Full Text] [Related]
18. [Indices of the immune status of recurrent herpes patients being treated with a herpes polyvaccine]. Belokrinitskiĭ DV; Karpovich LG; Barinskiĭ IF; Bukovskaia SN; Semenova TB Vopr Virusol; 1987; 32(2):229-33. PubMed ID: 3037800 [TBL] [Abstract][Full Text] [Related]
19. [Herpetic pathology and current methods of treating herpetic lesions]. Zhdanov VM; Barinskiĭ IF; Galegov GA; Ershov FI Sov Med; 1983; (10):65-9. PubMed ID: 6362030 [No Abstract] [Full Text] [Related]
20. [Specific vaccine therapy and recurrent herpetic keratitis]. Preste E Ann Ottalmol Clin Ocul; 1966 Aug; 92(8):608-12. PubMed ID: 4295886 [No Abstract] [Full Text] [Related] [Next] [New Search]